logo
Bitcoin 'Accumulator' Better Fit for Corporates Than Dollar-Cost Averaging Strategy, Research Suggests

Bitcoin 'Accumulator' Better Fit for Corporates Than Dollar-Cost Averaging Strategy, Research Suggests

Yahoo4 hours ago

Corporate adoption of bitcoin BTC is well-known, and most of it involves a classic buy-and-hold strategy, loosely analogous to the dollar-cost averaging (DCA) strategy.
While investors of all kinds widely prefer DCA, new research by crypto options market maker Orbit Markets shows that since 2023, it has underperformed a structured product called an "accumulator," popularly known as "I Kill You Later" in traditional markets.
"Our backtest results show that the accumulator strategy outperformed DCA over the past 2.5-year period," said Pulkit Goyal, head of trading at Orbit Markets, told CoinDesk. "Three-month accumulators delivered a 10% outperformance, while longer tenors did even better — six- and twelve-month accumulators outperformed by 13% and 26%, respectively."
Goyal added that accumulators offer a disciplined, cost-effective approach to token accumulation, making them "a natural fit for crypto treasury companies' use case."
Both DCA and the accumulator operate the same principle – stop timing the market. While DCA simplifies investing by spreading out purchases over time, the accumulator helps acquire coins at a discount in a structured setup and helps outperform DCA during bull runs.
The accumulator is a time-structured product linked to the performance of an underlying asset with an upside knock-out barrier – level, which, if hit, terminates the structure.
Here is how it works: An investor agrees to buy a certain amount of the underlying asset at a fixed, discounted price (the Strike) over regular intervals, such as daily or weekly, for a set period.
The product runs through the pre-determined set period unless terminated early due to an early knock-out by the spot price rising to the barrier.
Note that the investor has an obligation, not a choice, to buy the asset at the discounted strike price and must double the buy in case the spot price dips below the discounted strike.
Consider a three-month accumulator where an investor commits to buy $1,000 worth of BTC every week at a strike price of $94,500, with a knock-out level of $115,000.
The strike price of $94,500 is 90% of the current spot price of around $105,000. In other words, the investor is now mandated to snap up coins at a discount, assuming the spot price holds above the strike price of $94,500 and below the knock-out of $115,000.
If BTC tops the knock-out level, the structure is terminated.
If the price falls below $94,500, the investor doubles the weekly purchase to $ 4,000 at the same strike, i.e., $94,500 – there is no way out, meaning the investor ends up buying at a price higher than the prevailing market rate. (this is why it gets the nickname "I kill you later.")
Hence, the accumulator is not suitable for day traders, short-term traders and speculators and may not necessarily outperform DCA in a bear market.
Orbit backtested a three-month BTC accumulator, spanning from January 2023 to June 13, 2025, assuming the investor continuously rolled into a new one upon reaching maturity or a premature knock-out event.
Results show an average BTC acquisition cost of $39,035 for the accumulator, which is 10% lower than the DCA average purchase price of $43,329. The DCA involved investing a fixed dollar amount in BTC every week.
Longer maturity accumulators of 6 and 12 months performed even better, achieving average costs of $37,654 and $32,079, respectively, outperforming DCA by 13% and 26%.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Tron Inc. Deal Gives Justin Sun's Father Control of Public Firm Via $100M Token Deal
Tron Inc. Deal Gives Justin Sun's Father Control of Public Firm Via $100M Token Deal

Yahoo

time27 minutes ago

  • Yahoo

Tron Inc. Deal Gives Justin Sun's Father Control of Public Firm Via $100M Token Deal

A Securities and Exchange Commission (SEC) filing posted Monday night outlines the relationship between Tron DAO, Justin Sun, and SRM Entertainment, a Nevada company in the process of changing its name to Tron Inc. The filing details a $100 million private investment in public equity (PIPE) deal, paid entirely in TRX TRX tokens, that gives Sun's father, Weike Sun, board control and positions Tron-aligned advisors in key governance roles. Weike was named chairman, while Zhihong Liu, also known as Steve Liu, a strategic adviser to Tron DAO and the CEO of stablecoin issuer Techteryx, and Zi Yang, a senior executive at Tronscan, joined the board's audit, compensation, and nominating committees, according to the filing. The deal was structured as a private investment in public equity (PIPE) deal. An investment vehicle owned by Weike purchased 100,000 shares of SRM Series B preferred Stock via TRX tokens, convertible into 200 million common shares, and received 220 million warrants at a strike price of $0.50. Despite the appearance of alignment, Tron DAO has no direct investment, governance rights, or formal role in the SRM deal, said Liu. "Tron DAO is not really any part of the deal for SRM. It's more of the senior Sun's transaction." The DAO itself is not mentioned in the 8K filing either. Its influence appears to be indirect, reflected through the backgrounds of newly appointed board members tied to the Tron ecosystem. According to the Financial Times, the renamed firm plans to buy and hold up to $210 million worth of TRX, similar to how MicroStrategy built a bitcoin-based corporate treasury. The deal was arranged by Dominari Securities, a brokerage affiliated with Dominari Holdings, whose advisory board includes Donald Trump Jr. and Eric Trump and is located within Trump Tower in Manhattan. Dominari Securities was paid $50,000 for the counsel for the transaction, according to the 8K filing. SRM, the listed Tron entity, is down 15%, trading at $7.73 as the market closed in New York. The TRX token is down 2.5%, trading at $0.27. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Why AI Stock Jabil Crushed the Market on Tuesday
Why AI Stock Jabil Crushed the Market on Tuesday

Yahoo

time28 minutes ago

  • Yahoo

Why AI Stock Jabil Crushed the Market on Tuesday

The contract electronics manufacturer delivered solid third-quarter results. Its business is benefiting handsomely from the proliferation of artificial intelligence (AI), and it's also doing well supplying cloud computing customers. 10 stocks we like better than Jabil › The intense take-up of artificial intelligence (AI) has been a powerful motor driving contract electronics manufacturer Jabil (NYSE: JBL) lately. It also helped power the company's latest quarterly results, which were published Tuesday morning. Investors very much liked what they saw in the numbers, and rewarded the company by boosting its share price nearly 9% higher on the day. Jabil's fiscal third quarter of 2025 results were posted before market open, and they set the tone for the stock that day. Revenue rose by a sturdy 16% year over year to just over $7.8 billion, handily beating the average analyst estimate of $7 billion. The story was similar on the bottom line, with "core" -- i.e. non-GAAP (generally accepted accounting principles) adjusted -- net income rising 21% to $279 million, or $2.55 per share. The latter number was well above the consensus $2.29 projected by analysts tracking Jabil stock. Management attributed the double-digit gains to growth in expanding end markets, such as data centers infrastructure, and cloud computing. Its intelligent infrastructure segment did particularly well, thanks greatly to intensifying demand for artificial intelligence (AI) solutions. Meanwhile, Jabil announced it is to invest roughly $500 million to expand its manufacturing footprint in the Southwest U.S., specifically targeting the AI and cloud businesses. The company wrote that this will "enable new large-scale manufacturing capabilities, capital investments, and workforce development." Such facilities should come onstream in mid-2026, it added. Jabil also proffered guidance for both its current quarter and the entirety of fiscal 2025. For the latter period, it's anticipating revenue of $29 billion, filtering down into adjusted net income of $9.33 per share. Those figures in fiscal 2024 were a respective $28.9 billion, and $8.49. Even with that post-earnings pop, Jabil remains a somewhat under-the-radar play on the explosion of AI. As such, I'd flag it as a sleeper stock in that pack, and one well worth consideration as a buy. Before you buy stock in Jabil, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Jabil wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $660,821!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $886,880!* Now, it's worth noting Stock Advisor's total average return is 791% — a market-crushing outperformance compared to 174% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Why AI Stock Jabil Crushed the Market on Tuesday was originally published by The Motley Fool Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

Cohere Health Tops Black Book Research Ratings for Clinical and Payer Data Interoperability at AHIP 25
Cohere Health Tops Black Book Research Ratings for Clinical and Payer Data Interoperability at AHIP 25

Associated Press

time28 minutes ago

  • Associated Press

Cohere Health Tops Black Book Research Ratings for Clinical and Payer Data Interoperability at AHIP 25

LAS VEGAS, NV / ACCESS Newswire / June 16, 2025 / Black Book Research, an independent healthcare technology research firm, announced today at AHIP 25 that Cohere Health has received the highest ratings in Clinical and Payer Data Interoperability based on comprehensive feedback from 628 managed care and health plan IT, clinical, and finance leaders surveyed in Q1-Q2 2025. The qualitative key performance indicators developed specifically for payer interoperability and data exchange are considered by Black Book Research to be the most reliable measures of true health plan performance satisfaction. Respondents identified Cohere Health's strengths in Clinical Data Interoperability, specifically highlighting exceptional accuracy and completeness of clinical data exchange and real-time integration capabilities. Additionally, participants emphasized the intuitive, user-friendly nature of Cohere's provider portal, reporting significant improvements in quality and risk care gap closure, as well as high provider satisfaction ratings. Survey feedback also emphasized Cohere Health's real-time clinical data updates, ensuring timeliness and precision in clinical information exchange. In Payer Data Interoperability, survey participants recognized Cohere Health for exceeding interoperability mandates through a highly scalable and secure hub-and-spoke model. Respondents underscored the substantial administrative efficiencies achieved, noting remarkable reductions in complexity, accelerated data transitions between health plans, and robust security and privacy measures that met or exceeded industry expectations. 'The survey results clearly demonstrate that Cohere Health has consistently delivered on key interoperability requirements valued by payers and health plans,' said Doug Brown, Founder of Black Book Research. 'These findings are particularly relevant for organizations navigating complex regulatory environments and seeking operational efficiency.' Industry stakeholders can access complimentary managed care-focused research reports at the Black Book homepage. Detailed competitive intelligence reports on the twenty vendors covered are also available by contacting [email protected]. About Black Book Research Black Book Research is an independent, vendor-agnostic market research firm dedicated to healthcare technology and services. Black Book Research is not affiliated with AHIP or its association management, nor is it sponsored by or financially linked to Cohere Health. Contact InformationPress Office 8008637590 SOURCE: Black Book Research press release

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store